{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T13:28:01Z","timestamp":1781702881443,"version":"3.54.5"},"reference-count":42,"publisher":"Informa UK Limited","issue":"14","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Microbiol."],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.2217\/fmb-2019-0199","type":"journal-article","created":{"date-parts":[[2019,9,2]],"date-time":"2019-09-02T13:43:01Z","timestamp":1567431781000},"page":"1235-1242","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":34,"title":["Sarecycline: A Narrow Spectrum Tetracycline for the Treatment of Moderate-to-Severe Acne Vulgaris"],"prefix":"10.1080","volume":"14","author":[{"given":"Angela Yen","family":"Moore","sequence":"first","affiliation":[{"name":"Arlington Research Center, Inc., Arlington, TX76011, USA"},{"name":"Baylor University Medical Center, Dallas, TX75246, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Elizze M","family":"Charles","sequence":"additional","affiliation":[{"name":"Medical City Weatherford Dermatology Residency Program, Weatherford, TX76086, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Moore","sequence":"additional","affiliation":[{"name":"Arlington Research Center, Inc., Arlington, TX76011, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2019,9,2]]},"reference":[{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12149"},{"issue":"4","key":"e_1_3_3_4_1","first-page":"577","article-title":"Prevalence of facial acne in adults","volume":"41","author":"Goulden V","year":"1999","unstructured":"Goulden V , StablesGI, CunliffeWJ. Prevalence of facial acne in adults. J. Am. Acad. Dermatol.41(4), 577\u2013580 (1999).","journal-title":"J. Am. Acad. Dermatol."},{"issue":"2","key":"e_1_3_3_5_1","first-page":"63","article-title":"Acne vulgaris: review and guidelines","volume":"21","author":"Ramos-E-Silva M","year":"2009","unstructured":"Ramos-E-Silva M , CarneiroSC. Acne vulgaris: review and guidelines. Dermatol. Nurs.21(2), 63\u201368 (2009).","journal-title":"Dermatol. Nurs."},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2004.05749.x"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2003.12321.x"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)01046-0"},{"issue":"6","key":"e_1_3_3_9_1","first-page":"655","article-title":"The development of antimicrobial resistance due to the antibiotic treatment of acne vulgaris: a review","volume":"9","author":"Patel M","year":"2010","unstructured":"Patel M , BoweWP, HeughebaertC, ShalitaAR. The development of antimicrobial resistance due to the antibiotic treatment of acne vulgaris: a review. J. Drugs Dermatol.9(6), 655\u2013664 (2010).","journal-title":"J. Drugs Dermatol."},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200304050-00002"},{"issue":"11","key":"e_1_3_3_11_1","first-page":"1407","article-title":"Doxycycline and minocycline for the management of acne: a review of efficacy and safety with emphasis on clinical implications","volume":"9","author":"Kircik LH","year":"2010","unstructured":"Kircik LH . Doxycycline and minocycline for the management of acne: a review of efficacy and safety with emphasis on clinical implications. J. Drugs Dermatol.9(11), 1407\u20131411 (2010).","journal-title":"J. Drugs Dermatol."},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.12370"},{"issue":"4","key":"e_1_3_3_13_1","first-page":"18","article-title":"Status Report from the Scientific Panel on Antibiotic Use in Dermatology of the American Acne and Rosacea Society: part 1: antibiotic prescribing patterns, sources of antibiotic exposure, antibiotic consumption and emergence of antibiotic resistance, impact of alterations in antibiotic prescribing, and clinical sequelae of antibiotic use","volume":"9","author":"Del Rosso JQ","year":"2016","unstructured":"Del Rosso JQ , WebsterGF, RosenTet al. Status Report from the Scientific Panel on Antibiotic Use in Dermatology of the American Acne and Rosacea Society: part 1: antibiotic prescribing patterns, sources of antibiotic exposure, antibiotic consumption and emergence of antibiotic resistance, impact of alterations in antibiotic prescribing, and clinical sequelae of antibiotic use. J. Clin. Aestheti. Dermatol.9(4), 18 (2016).","journal-title":"J. Clin. Aestheti. Dermatol."},{"issue":"2","key":"e_1_3_3_14_1","first-page":"208","article-title":"Efficacy of tetracyclines in the treatment of acne vulgaris: a review","volume":"158","author":"Simonart T","year":"2008","unstructured":"Simonart T , DramaixM, DeMaertelaer V. Efficacy of tetracyclines in the treatment of acne vulgaris: a review. Br. J. Dermatol.158(2), 208\u2013216 (2008).","journal-title":"Br. J. Dermatol."},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.7.1.55"},{"issue":"6","key":"e_1_3_3_16_1","first-page":"341","article-title":"The effect of oral tetracycline HCl and doxycycline on the intestinal flora","volume":"12","author":"Hinton NA","year":"1970","unstructured":"Hinton NA . The effect of oral tetracycline HCl and doxycycline on the intestinal flora. Curr. Ther. Res. Clin. Exp.12(6), 341\u2013352 (1970).","journal-title":"Curr. Ther. Res. Clin. Exp."},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/phar.1636"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1128\/MMBR.65.2.232-260.2001"},{"issue":"4","key":"e_1_3_3_19_1","first-page":"6","article-title":"The anti-inflammatory effects of tetracyclines","volume":"75","author":"Weinberg JM","year":"2005","unstructured":"Weinberg JM . The anti-inflammatory effects of tetracyclines. Cutis75(Suppl. 4), 6\u201311 (2005).","journal-title":"Cutis"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.2174\/1874210601408010109"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.det.2007.01.012"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01297-18"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.8.6.713"},{"key":"e_1_3_3_24_1","unstructured":"US Securities and Exchange Commission . Paratek prospectus supplement (2015). www.sec.gov\/Archives\/edgar\/data\/1178711\/000156459016014314\/prtk-10k_20151231.htm"},{"key":"e_1_3_3_25_1","unstructured":"US FDA Center for Drug Evaluation and Research . Multi Discipline Review (2018). www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2018\/209521Orig1s000TOC.cfm"},{"issue":"3","key":"e_1_3_3_26_1","first-page":"333","article-title":"Efficacy and safety of sarecycline, a novel, once-daily, narrow spectrum antibiotic for the treatment of moderate to severe facial acne vulgaris: results of a Phase II, dose-ranging study","volume":"17","author":"Leyden JJ","year":"2018","unstructured":"Leyden JJ , SniukieneV, BerkDR, KaoukhovA. Efficacy and safety of sarecycline, a novel, once-daily, narrow spectrum antibiotic for the treatment of moderate to severe facial acne vulgaris: results of a Phase II, dose-ranging study. J. Drugs Dermatol.17(3), 333\u2013338 (2018).","journal-title":"J. Drugs Dermatol."},{"issue":"9","key":"e_1_3_3_27_1","first-page":"987","article-title":"Once-daily oral sarecycline 1.5 mg\/kg\/day is effective for moderate to severe acne vulgaris: results from two identically designed, Phase III, randomized, double-blind clinical trials","volume":"17","author":"Moore A","year":"2018","unstructured":"Moore A , GreenLJ, BruceSet al. Once-daily oral sarecycline 1.5 mg\/kg\/day is effective for moderate to severe acne vulgaris: results from two identically designed, Phase III, randomized, double-blind clinical trials. J. Drugs Dermatol.17(9), 987\u2013996 (2018).","journal-title":"J. Drugs Dermatol."},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2015.09.008"},{"issue":"1","key":"e_1_3_3_29_1","first-page":"1","article-title":"In vitro studies on colonization resistance of the human gut microbiota to Candida albicans and the effects of tetracycline and Lactobacillus plantarum LPK","volume":"4","author":"Payne S","year":"2003","unstructured":"Payne S , GibsonG, WynneA, HudspithB, BrostoffJ, TuohyK. In vitro studies on colonization resistance of the human gut microbiota to Candida albicans and the effects of tetracycline and Lactobacillus plantarum LPK. Curr. Issues Intest. Microbiol.4(1), 1\u20138 (2003).","journal-title":"Curr. Issues Intest. Microbiol."},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1155\/2008\/493508"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2015.01543"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/ismej.2007.3"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-016-0294-z"},{"key":"e_1_3_3_34_1","first-page":"692","article-title":"The effect of long-term antibiotic therapy in patients with cystic fibrosis of the pancreas","volume":"6","author":"Shwachman H","year":"1958","unstructured":"Shwachman H , FeketeE, KulczyckiL, FoleyG. The effect of long-term antibiotic therapy in patients with cystic fibrosis of the pancreas. Antibiot. Annu.6, 692\u2013699 (1958).","journal-title":"Antibiot. Annu."},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1136\/adc.42.223.311"},{"issue":"4","key":"e_1_3_3_36_1","first-page":"351","article-title":"The incidence of staining of permanent teeth by the tetracyclines","volume":"103","author":"Conchie J","year":"1970","unstructured":"Conchie J , MunroeJ, AndersonD. The incidence of staining of permanent teeth by the tetracyclines. Can. Med. Assoc. J.103(4), 351 (1970).","journal-title":"Can. Med. Assoc. J."},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.14219\/jada.archive.1983.0111"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1177\/0009922806290026"},{"issue":"55679","key":"e_1_3_3_39_1","first-page":"82","article-title":"Prescription drug products; doxycycline and penicillin G procaine administration for inhalational anthrax (post-exposure)","volume":"66","author":"(Fda) FaDA","year":"2001","unstructured":"(Fda) FaDA . Prescription drug products; doxycycline and penicillin G procaine administration for inhalational anthrax (post-exposure). Fed. Reg.66(55679), 82 (2001).","journal-title":"Fed. Reg."},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-017-1797-9"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkx245"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1991.01680020078009"},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(97)70307-X"},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1988.tb02566.x"}],"container-title":["Future Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/fmb-2019-0199","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T06:39:15Z","timestamp":1719124755000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/fmb-2019-0199"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":42,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["10.2217\/fmb-2019-0199"],"URL":"https:\/\/doi.org\/10.2217\/fmb-2019-0199","relation":{},"ISSN":["1746-0913","1746-0921"],"issn-type":[{"value":"1746-0913","type":"print"},{"value":"1746-0921","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifmb20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifmb20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2019-07-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-08-13","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-09-02","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}